The Effect of Stressor Controllability on Stress-Induced Neuropeptide mRNA Expression within the Paraventricular Nucleus of the Hypothalamus
dc.contributor.author | Helmreich, | en_US |
dc.contributor.author | Watkins, | en_US |
dc.contributor.author | Deak, | en_US |
dc.contributor.author | Maier, | en_US |
dc.contributor.author | Akil, | en_US |
dc.contributor.author | Watson, | en_US |
dc.date.accessioned | 2010-06-01T20:53:57Z | |
dc.date.available | 2010-06-01T20:53:57Z | |
dc.date.issued | 1999-02 | en_US |
dc.identifier.citation | Helmreich, ; Watkins, ; Deak, ; Maier, ; Akil, ; Watson, (1999). "The Effect of Stressor Controllability on Stress-Induced Neuropeptide mRNA Expression within the Paraventricular Nucleus of the Hypothalamus." Journal of Neuroendocrinology 11(2): 121-128. <http://hdl.handle.net/2027.42/73995> | en_US |
dc.identifier.issn | 0953-8194 | en_US |
dc.identifier.issn | 1365-2826 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73995 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10048467&dopt=citation | en_US |
dc.format.extent | 312270 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd. | en_US |
dc.rights | 1999 British Neuroendocrine Group | en_US |
dc.subject.other | CRH | en_US |
dc.subject.other | AVP | en_US |
dc.subject.other | Coping | en_US |
dc.subject.other | Corticosterone | en_US |
dc.subject.other | Rat | en_US |
dc.title | The Effect of Stressor Controllability on Stress-Induced Neuropeptide mRNA Expression within the Paraventricular Nucleus of the Hypothalamus | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, MI, USA, | en_US |
dc.contributor.affiliationother | University of Colorado, Boulder, CO, USA. | en_US |
dc.identifier.pmid | 10048467 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73995/1/j.1365-2826.1999.00300.x.pdf | |
dc.identifier.doi | 10.1046/j.1365-2826.1999.00300.x | en_US |
dc.identifier.source | Journal of Neuroendocrinology | en_US |
dc.identifier.citedreference | Herman J, Prewitt M, Cullinan W-F. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit Rev Neurobiol 1996 10 371 394 | en_US |
dc.identifier.citedreference | Li H, Ericsson A-Y, Sawchenko P. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci 1996 93 2359 2364 | en_US |
dc.identifier.citedreference | Vale W, Vaughn J, Smith M, Yammamoto G, Rivier J, Rivier C. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substance on cultured corticotropic cells. Endocrinol 1983 113 1121 1131 | en_US |
dc.identifier.citedreference | Antoni F. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue cortiocotropin-releasing factor. Endocrine Rev 1986 7 351 378 | en_US |
dc.identifier.citedreference | Ceccatelli S, Eriksson M, HÖkfelt T. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin-, and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocr 1989 49 309 323 | en_US |
dc.identifier.citedreference | Merchenthaler I. Enkephalin-immunoreactive neurons in the parvicellular suddivisions of the paraventricular nucleus project to the external zone of the median eminence. J Comp Neurol 1992 326 112 120 | en_US |
dc.identifier.citedreference | Pretel S & Piekut D. Coexistence of corticotropin-releasing factor and enkephalin in the paraventricular nucleus of the rat. J Comp Neurol 1990 294 192 201 | en_US |
dc.identifier.citedreference | Plotsky P, Bruhn T, Vale W. Evidence for multifactoral regulation of the adrenocorticotropin secretory response to hemodynamic stimuli. Endocrinol 1985 116 633 639 | en_US |
dc.identifier.citedreference | Plotsky P, Bruhn T, Vale W. Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinol 1985 117 323 329 | en_US |
dc.identifier.citedreference | Watts A. Ether anesthesia diffentially affects the content of prepro-corticotropin-releasing hormone, prepro-neurotensin/neuromedin N and prepro-enkephalin mRNAs in the hypothalamic paraventricular nucleus of the rat. Brain Res 1991 544 353 357 | en_US |
dc.identifier.citedreference | Ceccatelli S & Orazzo C. Effect of different types of stressors on peptide messenger ribonucleic acids in the hypothalamic paraventricular nucleus. Acta Endocrinol 1993 128 485 492 | en_US |
dc.identifier.citedreference | Harbuz M & Lightman S. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J Endocrinol 1989 122 705 711 | en_US |
dc.identifier.citedreference | Maier S, Drugan R, Grau J. Controllability, coping behavior, and stress-induced analgesia in the rat. Pain 1982 12 47 56 | en_US |
dc.identifier.citedreference | Telner J, Merali Z, Singhal R. Stress controllability and plasma prolactin levels in the rat. Psychoneuroendo 1982 7 361 364 | en_US |
dc.identifier.citedreference | Murison R & Isaksen E. Gastric ulceration and adrenocortical activity after inescapable and escapable pre-shock in rats. Scan J Psychol. 1982 1 (Suppl): 133 137 | en_US |
dc.identifier.citedreference | Weiss J, Goodman P, Losito B, Corrigan S, Charry J, Bailey W. Behavioral depression produced by an uncontrollable stressor: relationship to norepeinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res Rev 1981 3 167 205 | en_US |
dc.identifier.citedreference | Shors T, Seib T, Levine S, Thompson R. Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science 1989 244 224 226 | en_US |
dc.identifier.citedreference | Seligman M & Weiss J. Coping Behavior: Learned helplessness, physiological change, and learned activity. Behav Res Ther 1980 18 459 512 | en_US |
dc.identifier.citedreference | Maier S, Ryan S, Barksdale C, Kalin N. Stressor controllability and the pituitary-adrenal system. Behav Neuroscience 1986 100 669 674 | en_US |
dc.identifier.citedreference | Prince C & Anisman H. Situation specific effects of stressor controllability on plasma corticosterone changes in mice. Pharmacol Biochem Behav 1990 37 613 621 | en_US |
dc.identifier.citedreference | Swenson R & Vogel W. Plasma catecholamine and corticosterone as well as brain catechoamine changed during coping in rats exposed to stressful footshock. Pharm Biochem Behav 1983 18 689 693 | en_US |
dc.identifier.citedreference | Haracz J, Minor T, Wilkins J, Zimmerman E. Learned helplessness: an experimental model of the DST in rats. Biol Psychiatry 1988 23 388 396 | en_US |
dc.identifier.citedreference | Compas B, Orosan P, Grant K. Adolescent stress and coping: Implications for psychopathology during adolescence. J Adolescence 1993 16 331 349 | en_US |
dc.identifier.citedreference | Paykel E. Life events, socisl support, and depression. Acta Psychiatr Scand. 1994 377 (Suppl): 50 58 | en_US |
dc.identifier.citedreference | Young E, Haskett R, Grunhaus L, Pande A, Weinberg V, Watson S, Akil H. Increased activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry 1994 51 701 707 | en_US |
dc.identifier.citedreference | Matthews J, Akil H, Greden J, Charney D, Weinberg V, Rodenbaum A, Watson S. β-Endorphin/β-Lipotropin immunoreactivity in endogenous depression. Arch Gen Psychiatry 1986 43 374 381 | en_US |
dc.identifier.citedreference | Purba J, Hoogendijk W, Hofman M, Swaab D. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 1996 53 137 143 | en_US |
dc.identifier.citedreference | Raadsheer F, Hoogendijk W, Stan F, Tilders F, Swaab D. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994 60 436 444 | en_US |
dc.identifier.citedreference | Modell S, Yassouridis A, Huber J, Holsboer F. Corticosteroid receptor function is decreased in depressed patients. Neuroendo 1997 65 216 222 | en_US |
dc.identifier.citedreference | Romero M, Plotsky P, Sapolsky R. Patterns of adrenocorticotropin secretagogue release with hypoglycemia, novelty, and restraint after colchicine blockade of axonal transport. Endocrinol 1993 132. 199. | en_US |
dc.identifier.citedreference | Romero L, Levine S, Sapolsky R. Patterns of adrenocorticotropin secretagog release in response to social interactions and various degrees of novelty. Psychoneuroendo 1995 20 183 191 | en_US |
dc.identifier.citedreference | Darlington D, Baraclough C, Gann D. Hypotensive hemorrhage elevates corticotropin-releasing hormone messenger ribonucleic acid (mRNA) but not vasopressin mRNA in the rat hypothalamus. Endocrinol 1992 130 1281 1288 | en_US |
dc.identifier.citedreference | Miller A, Spencer R, Pulera M, Kang S, Ewen B, Stein M. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: Implications for the dexamethaone suppression test. Biol Psychiatry 1992 32 850 869 | en_US |
dc.identifier.citedreference | Maier S. Learned helplessness and animal models of depression. Prog Neuro-Psycholopharmacol Biol Psychiat 1984 8 435 446 | en_US |
dc.identifier.citedreference | Schmidt E, Binnekade R, Janszen A, Tilders F. Short stressor induced long-lasting increases of vasopressin stores in hypothalamic corticotropin-releasing hormone (CRH) neurons in adult rats. J Neuroendocrinol 1996 8 703 712 | en_US |
dc.identifier.citedreference | Ma X-M, Levy A, Lightman S. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronucleur RNA. Endocrinol 1997 138 4351 4357 | en_US |
dc.identifier.citedreference | Wotjak C, Kubota M, Liebsch G, Montkowski A, Holsboer F, Neumann I, Landgraf R. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?. J Neurosci 1996 16 7725 7732 | en_US |
dc.identifier.citedreference | Imaki T, Naruse M, Harada S, Chikada N, Imaki J, Onodera H, Demura H, Vale W. Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. Mol Brain Res 1996 38 166 170 | en_US |
dc.identifier.citedreference | Nicot A, Rowe W, de Kloet E, Betancur C, Jessop D, Lightman S, Quirion R, Rostene W, Berod A. Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus. J Neuroendo 1997 9 263 269 | en_US |
dc.identifier.citedreference | Rowe W, Viau V, Meaney M, Quirion R. Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: evidence for the participation of the paraventricular nucleus. J Neuroendo 1995 7 109 117 | en_US |
dc.identifier.citedreference | Rowe W, Nicot A, Sharma S, Gully D, Walker C, Rostene W, Meaney M, Quirion R. Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal acitivity. Neuroendocrinology 1997 66 75 85 | en_US |
dc.identifier.citedreference | Nicholson S, Adrian T, Gillham B, Jones M, Bloom S. Effect of hypothalamic neuropeptides on corticotrophin release form quarters of rat anterior pituitary gland in vitro. J Endocr 1984 100 219 226 | en_US |
dc.identifier.citedreference | Brooks N & Challis J. Effects of CRF, AVP, and opioid peptides on pituitary-adrenal responses in sheep. Peptides 1989 10 1291 1293 | en_US |
dc.identifier.citedreference | Giusti M, Marini G, Uggias B, Sessarego P, Besser G, Grossman A, Giordano G. The effect of a met-enkephalin analogue on growth hormone, prolactin, gonadotropins, cortisol, and thyroid stimulating hormone in healthy elderly men. Acta Endocrinologica 1992 127 205 209 | en_US |
dc.identifier.citedreference | Iyengar S, Kim H, Wood P. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat. J Pharm Exp Therapeutics 1986 238 429 436 | en_US |
dc.identifier.citedreference | Allolio B, Deuss U, Kaulen D, Leonhardt U, Kallabis D, Hamel E, Winkelmann W. FK 33–824, a Met-Enkaphalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing’s disease. Endocrinology 1986 63 1427 1431 | en_US |
dc.identifier.citedreference | Buckingham J & Cooper T. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology 1984 38 411 417 | en_US |
dc.identifier.citedreference | Sawchenko P. Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity. J Neurosci 1987 7 1093 1106 | en_US |
dc.identifier.citedreference | Swanson L & Simmons D. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol 1989 285 413 435 | en_US |
dc.identifier.citedreference | Watts A & Sanchez-Watts G. Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone. J Physiol 1995 3 721 736 | en_US |
dc.identifier.citedreference | Swanson L. Biochemical switching in hypothalamic circuits mediating responses to stress. Prog Brain Res 1991 87 181 200 | en_US |
dc.identifier.citedreference | Watts A & Sanchez-Watts G. Physiological regulation of peptide messenger RNA colocalization in rat hypothalamic paraventricular medial parvicellular neurons. J Comp Neurol 1995 352 501 514 | en_US |
dc.identifier.citedreference | Watkins L, Wiertelak E, Maier S. The amygdala is necessary for the expresssion of conditioned but not unconditioned analgesia. Behav Neuroscience 1993 107 402 405 | en_US |
dc.identifier.citedreference | Koob G, Heinrichs S, Pich E, Menzaghi F, Baldwin H, Miczek K, Britton K The role of corticotropin-releasing factor in behavioral responses to stress. In: Chadwick DJ, Marsh J, Ackrill K, eds. Corticotropin-releasing Factor (Ciba Foundation Symposium 172 ). Chichester: Wiley, 1993 277–295 | en_US |
dc.identifier.citedreference | Maier S, Grahn R, Kalman B, Sutton L, Wiertelak E, Watkins L. The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock. Behav Neuroscience 1993 107 377 388 | en_US |
dc.identifier.citedreference | Mamalaki E, Kvetnansky R, Brady LS, Gold PW, Herkenham M. Repeated immobilization stress alters tyrosine hydroxylase, corticotropin-releasing hormone and corticosteroid receptor messenger ribonucleic acid levels in rat brain. J Neuroendocrinol 1992 4 689 699 | en_US |
dc.identifier.citedreference | Makino S, Gold P, Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis: comparison with the effects on the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 1994 657 141 149 | en_US |
dc.identifier.citedreference | Day H & Akil H Systemic and central administration of interleukin-1-beta induces differential patterns of c-fos activation in rat brain: implications for mechanism of action. In: Society for Neuroscience Annual Meeting, San Diego, 1995. Washington: The Society for Neuroscience. | en_US |
dc.identifier.citedreference | Grahn R, Kalman B, Brennan F, Watkins L, Maier S. The elevated plus-maze is not sensitive to the effect of stressor controllability in rats. Pharm Biochem Behav 1995 52 565 570 | en_US |
dc.identifier.citedreference | Schafer K-H, Herman J, Watson S In situ hybridization histochemistry. In: London E, ed, Imaging Drug Action in the Brain. Boca Raton: CRC Press, 1993 337–377 | en_US |
dc.identifier.citedreference | Alexander M, Miller M, Dorsa D, Bullock B, Melloni R, Dobner P, Leeman S. Distribution of neurotensin/neuromedi N mRNA in rat forebrain: Unexpected abundance in hippocampus and subiculum. Proc Natl Acad Sci 1989 86 5202 5206 | en_US |
dc.identifier.citedreference | Curran E & Watson S. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: A double in situ hybiridization study. J Comp Neurol 1995 361 57 76 | en_US |
dc.identifier.citedreference | Day HEW & Akil H. Differential pattern of c-fos mRNA in rat brain following central and systemic adminstration of interleukin-1-Beta: implications for mechanism of action. Neuroendocrinol 1996 63 207 218 | en_US |
dc.identifier.citedreference | Herman J, Cullinan W, Watson S. Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J Neuroendocrinol 1994 6 433 442 | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.